EG ·
HALOPROL 5mg 3/AMP
HALOPROL 5mg 3/AMP
Composition
These source-reported data require scientific review and are not treatment advice.
HALOPERIDOL
· AMOUNT_PER_UNIT
HALOPERIDOL
5.00000 MG · AMOUNT_PER_UNIT
Registration
Packages and prices
AMPOULE
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| HALOPERIDOL 10ML ORAL DROPS | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, dosage_form, route | — EGP |
| HALDOL DECANOAS 50 MG 1 AMP | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis | — EGP |
| HALOPERIDOL RETARD 50MG 1/AMP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| HALONACE 10 ML ORAL DROPS | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| HALDOL 2MG\15ML GOUTTES 2 | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| HALOPERIDOL 1MG/10MLAMP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| Haloprol Decanoase 100mg/1ml 5amp | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| HALONACE 1.5 MG 10 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| SAFINACE 1.5mg 50/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| NEXIUM 40mg 1 VIAL | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| HALDOL 50 MG /1 ML AMP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| HALDOL 2 MG /100 ML LIQUID | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |